UBS Group’s Entera Bio Ltd. Warrant ENTXW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,100
| Closed | -$81 | – | 8946 |
|
|
2023
Q1 | $81 | Buy |
3,100
+1,854
| +149% | +$48 | ﹤0.01% | 8171 |
|
|
2022
Q4 | $37 | Buy |
+1,246
| New | +$37 | ﹤0.01% | 9306 |
|
|
2022
Q2 | – | Sell |
-129
| Closed | – | – | 10121 |
|
|
2022
Q1 | $0 | Sell |
129
-1,284
| -91% | – | ﹤0.01% | 9930 |
|
|
2021
Q4 | $0 | Buy |
1,413
+235
| +20% | – | ﹤0.01% | 9648 |
|
|
2021
Q3 | $1K | Sell |
1,178
-347
| -23% | -$295 | ﹤0.01% | 8178 |
|
|
2021
Q2 | $2K | Buy |
+1,525
| New | +$2K | ﹤0.01% | 7920 |
|
|
2021
Q1 | – | Sell |
-2,737
| Closed | – | – | 8386 |
|
|
2020
Q4 | $0 | Sell |
2,737
-600
| -18% | – | ﹤0.01% | 7772 |
|
|
2020
Q3 | $0 | Sell |
3,337
-2,404
| -42% | – | ﹤0.01% | 7531 |
|
|
2020
Q2 | $1K | Buy |
5,741
+953
| +20% | +$166 | ﹤0.01% | 6975 |
|
|
2020
Q1 | $1K | Buy |
4,788
+294
| +7% | +$61 | ﹤0.01% | 6913 |
|
|
2019
Q4 | $1K | Buy |
4,494
+100
| +2% | +$22 | ﹤0.01% | 6923 |
|
|
2019
Q3 | $0 | Buy |
4,394
+1
| +0% | – | ﹤0.01% | 7245 |
|
|
2019
Q2 | $0 | Hold |
4,393
| – | – | ﹤0.01% | 7221 |
|
|
2019
Q1 | $1K | Buy |
4,393
+130
| +3% | +$30 | ﹤0.01% | 6750 |
|
|
2018
Q4 | $2K | Buy |
4,263
+692
| +19% | +$325 | ﹤0.01% | 6898 |
|
|
2018
Q3 | $3K | Buy |
+3,571
| New | +$3K | ﹤0.01% | 6751 |
|